AnticoagulantsPhysiologic, Pathologic, and Pharmacologic

Physiologic Inhibitors: Clinical and Physiological Manifestations of the Protein C Anticoagulant Pathway (C.T. Esmon). Protein S: Clinical and Laboratory Aspects (P.C. Comp). Antithrombin III (M. Manco-Johnson). Tissue Factor Pathway Inhibitor-A Regulator of Tissue Factor Induced Coagulation (M.S. Bajaj, A. Ameri, and S.P. Bajaj). Pathologic Inhibitors: Overview of Factor VIII Inhibitors (J.A. Penner). Immune Tolerance: Historical Perspective and Future Direction (D.M. DiMichele). Inhibitors of Factor VIII in Non-Hemophiliacs (D. Green). The Treatment of Acquired Hemophilia with Porcine Factor VIII Concentrate (C.M. Kessler). Use of Factor IX Complex Concentrates (Prothrombin Complex Concentrates) in Hemophiliacs with Inhibitor Antibodies to Factor VIII or Factor IX (J.M. Lusher). Pathologic Inhibitors (S. Glazer, U. Hedner, J.F. Falch). Lupus Anticoagulants (J.R. Chediak). Acquired von Willebrand's Disease (G.A. Soff). Acquired Inhibitors of Fibrin Stabilization: A Class of Hemorrhagic Disorders of Diverse Origins (L. Lorand). Pharmacologic Inhibitors: Heparin Therapy: Recent Advances in the Treatment of Venous and Arterial Thrombosis (G.F. Pineo, G.E. Raskob, and R.D. Hull). Warfarin Therapy (G.E. Raskob, P.C. Comp, G.F. Pineo, and R.D. Hull). Low Molecular Weight Heparins in the Management of Thrombotic Disorders (J. Fareed, D. Hoppensteadt, J.M. Walenga, W. Jeske, and A. Ahsan). Thrombolytic Therapy-Old and New (H.C. Kwaan).